One-pot synthesis of novel N,N -bis(isoxazol-5-yl)methyl tertiary arylamines via sequential diprop-3-ynylation and 1,3-dipolar cycloaddition from primary amines

Abstract

A simple and efficient one-pot multicomponent approach for the synthesis of tertiary arylamines bearing N,N-bis(isoxazol-5-yl)methyl groups is developed through reactions including sequential diprop-3-ynylation of primary amines with propargyl bromide in the presence of calcium hydride in N,N-dimethylformamide, and 1,3-dipolar cycloaddition with nitrile oxides generated in situ from hydroximyl chlorides in DMF-Et₃N. This protocol provides advantages such as high regioselectivity, easy operation, and moderate-to-good product yields with a wide substrate scope under mild conditions.

Keywords

1,3-dipolar cycloaddition diprop-3-ynylation nitrile oxides one-pot procedure

Introduction

Amines and isoxazoles are examples of nitrogen-containing compounds occupying a significant position in many fields such as organic chemistry, natural products, materials science, and pharmaceuticals. A secondary or tertiary amino group is often embedded as a structural motif in various biologically active compounds, which are important intermediates in the synthesis of pharmaceutically active substances, dyes, and fine chemicals.¹ The formation of C–N bonds between primary amines and organic halides has been applied as the major method to prepare secondary and tertiary amines.^2–4 Isoxazoles are important five-membered heteroaromatic molecules because of their wide applications in organic synthesis, pharmacy, chemistry, biologically active molecules, and advanced organic materials.^5,6 Among various synthetic methods for the synthesis of isoxazoles, the major routes typically involve 1,3-dipolar cycloadditions of alkenes/alkynes and nitrile oxides.^7–11 Introduction of the isoxazole scaffold into amine molecules represents a meaningful research area for the exploration of biologically active compounds and pharmaceutical agents. As far as we know, several synthetic methods have been developed for the construction of isoxazolyl-containing primary,^12–16 secondary, and tertiary amines.^17–21 However, there are very few reports on the synthesis of tertiary arylamines with isoxazolyl groups.²¹ Therefore, the development of simple, efficient, and economical protocols for the synthesis of isoxazole-containing tertiary arylamines using readily accessible starting material will be of great use. It is well known that multicomponent reactions (MCRs) are very useful synthetic methods because they allow rapid and convergent construction of complex molecules without the isolation of intermediates.^22–24 Moreover, this process is especially useful when the reaction intermediates are unstable and difficult to isolate. Obviously, in order to construct isoxazole scaffolds, the generation of terminal alkynes in situ from suitable precursors, followed by reaction with nitrile oxides in a one-pot process, would avoid the difficulties associated with the volatile nature of terminal alkynes. Herein, we report a highly regioselective one-pot MCR protocol for the facile synthesis of N,N-bis(isoxazol-5-yl)methyl tertiary arylamines involving in situ generation of terminal alkynes, N,N-di(prop-2-yn-1-yl) arylamines via diprop-3-ynylation of primary amines with propargyl bromide and 1,3-dipolar cycloaddition with nitrile oxides under mild reaction conditions.

Results and discussion

Initially, the diprop-3-ynylation conditions, such as the base and solvent, for the reaction of aniline (1a) with propargyl bromide were investigated (Scheme 1). It was reported that N,N-di(prop-2-yn-1-yl)aniline (2a) could be obtained in 80% yield by reaction of 1a with propargyl bromide in N,N-dimethylformamide (DMF) at room temperature in the presence of potassium carbonate.²⁵ Encouraged by this positive result, other polar solvents and bases were screened (Table 1, entries 2–8). Clearly, good yields of 2a in the model reaction were obtained in DMF and dimethylsulfoxide (DMSO) in the presence of different bases such as potassium carbonate, N,N-diisopropylethylamine (DIPEA), and calcium hydride (CaH₂) (Table 1, entries 1, 2, 7, and 8). Among them, CaH₂ was shown to be a very effective base for the reaction (Table 1, entry 8). After a considerable number of experiments, 2a was produced in 95% yield when the reaction was carried out in DMF at room temperature in the presence of CaH₂ (40 mol%) for 8 h (Table 1, entry 11).

Scheme 1.

Optimization of the one-pot reaction from aniline 1a.

Table 1.

Optimization of the diprop-2-ynylation conditions.^a

Entry	Solvent	Base (mol%)	Time (h)	Yield (%)^b
1	DMF	K₂CO₃ (20)	6	80^c
2	DMSO	K₂CO₃ (20)	6	78
3	Dioxane	K₂CO₃ (20)	6	65
4	MeCN	K₂CO₃ (20)	6	68
5	THF	K₂CO₃ (20)	6	60
6	DMF	Et₃N (20)	6	72
7	DMF	DIPEA (20)	6	82
8	DMF	CaH₂ (20)	6	85
9	DMF	CaH₂ (30)	6	90
10	DMF	CaH₂ (40)	6	92
11	DMF	CaH₂ (40)	8	95
12	DMF	CaH₂ (50)	8	96

DMF: N,N-dimethylformamide; DMSO: dimethylsulfoxide; THF: tetrahydrofuran; DIPEA: N,N-diisopropylethylamine.

Unless otherwise noted, all reactions were performed with 1.0 mmol of aniline, 4.0 mmol of propargyl bromide, and 5 mL of solvent at room temperature.

Isolated yield after column chromatography, based on aniline.

Cited in Ji et al.²⁵

Second, after completion of the diprop-3-ynylation, the excess propargyl bromide was removed by vacuum distillation. Without further isolation and purification of intermediate 2a, the subsequent [3 + 2] cycloaddition reaction with phenyl nitrile oxide, generated in situ from N-hydroxybenzimidoyl chloride (3a), affording N,N-bis[(3-phenylisoxazol-5-yl)methyl]aniline (4aa) was investigated. In our initial attempt involving treatment of the reaction system with 2 equiv. of 3a without adding another base for 6 h at room temperature resulted in 4aa in only 35% isolated yield. A further attempt to run the [3 + 2] cycloaddition reaction at an elevated temperature did not work well. However, when 3 equiv. of Et₃N were added to the reaction system, the corresponding product 4aa was isolated in 72% yield. Indeed, the use of 2.5 equiv. of 3a was found to increase the yield to 76%. In addition, it was found that using additional Et₃N and 3a did not increase the yield or shorten the reaction time. To our delight, when the reaction proceeded at 65 °C for 3 h, the desired product 4aa was isolated in 82% yield as the exclusive product.

The structure of 4aa was characterized by nuclear magnetic resonance (NMR) spectroscopic data. In the ¹H NMR spectrum of 4aa, a characteristic singlet appeared at 6.95 ppm due to the isoxazolyl C5–H proton and a singlet at 4.61 ppm for ArNCH₂ along with other protons. In the ¹³C NMR spectrum of 4aa, the ArNCH₂ carbon appeared at 48.23 ppm, carbons of C4 and C5 of the triazole ring appeared at 102.34 and 169.85 ppm, respectively, along with other carbons at expected chemical shifts.

Finally, the optimized reaction conditions were extended to a variety of primary aromatic amines and hydroximyl chlorides with different substituents (Scheme 2), and the corresponding results were summarized in Table 2. As observed in Table 2, for most of the examined substrates, the reactions were performed smoothly and the corresponding tertiary arylamines containing N,N-bis(isoxazol-5-yl)methyl groups were obtained. It is noteworthy that no significant difference in reactivity was observed for the examined arylamines substituted with 3-Me, 2-Me, and 4-Cl groups on the benzene rings (Table 2, entries 5–15). In general, aromatic nitrile oxides bearing electron-withdrawing groups such as chloro, bromo, and nitro (3e–g), as well as electron-donating groups such as methyl and methoxy (3b–d), and even N-hydroxy-2-methylbenzimidoyl chloride 3b bearing a hindered methyl substituent afforded the desired products in moderate to good yields (Table 2, entries 2–4, 6, 7, and 9–13). It was also observed that electron-deficient aromatic nitrile oxides were preferred over electron-rich nitrile oxides in this MCR. However, other electron-rich benzonitrile oxides such as 4-hydroxy-benzonitrile oxide and 4-(N,N-dimethylamino)benzonitrile oxide did not participate in this reaction (Table 2, entries 16 and 17). In addition, phenylacetonitrile oxide produced the corresponding product in moderate yield (Table 2, entry 14), while the aliphatic nitrile oxide n-butyl-nitrile oxide gave a low yield of the product 4di (Table 2, entry 15).

Scheme 2.

Access to N,N-bis(isoxazol-5-yl)methyl tertiary arylamines 4 by a diprop-3-ynylation and 1,3-dipolar cycloaddition sequence.

Table 2.

Sequential transformation of various arylamines and chlorooximes into N,N-bis(isoxazol-5-yl)methyl tertiary arylamines 4.^a

Entry	Ar (1)	R (3)	Product (4)	Yield (%)^b
1	C₆H₅ (1a)	C₆H₅ (3a)	4aa	82
2	C₆H₅ (1a)	2-CH₃C₆H₄ (3b)	4ab	70
3	C₆H₅ (1a)	3-CH₃C₆H₄ (3c)	4ac	76
4	C₆H₅ (1a)	3-CH₃OC₆H₄ (3d)	4ad	71
5	3-CH₃C₆H₄ (1b)	C₆H₅ (3a)	4ba	81
6	3-CH₃C₆H₄ (1b)	2-CH₃C₆H₄ (3b)	4bb	72
7	3-CH₃C₆H₄ (1b)	3-CH₃C₆H₄ (3c)	4bc	75
8	2-CH₃C₆H₄ (1c)	C₆H₅ (3a)	4ca	80
9	2-CH₃C₆H₄ (1c)	3-CH₃C₆H₄ (3c)	4cc	78
10	2-CH₃C₆H₄ (1c)	3-CH₃OC₆H₄ (3d)	4cd	72
11	2-CH₃C₆H₄ (1c)	4-ClC₆H₄ (3e)	4ce	86
12	2-CH₃C₆H₄ (1c)	4-BrC₆H₄ (3f)	4cf	84
13	2-CH₃C₆H₄ (1c)	4-NO₂C₆H₄ (3g)	4cg	88
14	4-ClC₆H₄ (1d)	C₆H₅CH₂ (3h)	4dh	62
15	4-ClC₆H₄ (1d)	CH₃CH₂CH₂ (3i)	4di	45
16	C₆H₅ (1a)	4-HOC₆H₄ (3j)	4aj	0
17	C₆H₅ (1a)	4-(Me₂N)C₆H₄ (3k)	4ak	0

All reactions were performed in 5 mL of DMF with 1.0 mmol of primary aromatic amine, 4.0 mmol of propargyl bromide, and 3.0 mmol of the chlorooxime.

Isolated yield based on the primary aromatic amine after column chromatography.

Conclusion

In summary, a facile and efficient, one-pot method for the preparation of N,N-bis(isoxazol-5-yl)methyl tertiary arylamines from primary amines, propargyl bromide, and hydroximyl chlorides has been developed. The procedure does not require isolation of the N,N-dipropargylated arylamine intermediates, and has considerable advantages in terms of its use of easily available substrates, its mild reaction conditions, its simple operation, and the moderate to good yields obtained.

Experimental

Melting points were measured with a Beijing-Taike X-4 apparatus and were uncorrected. ¹H NMR and ¹³C NMR spectra were recorded on an Avance-Bruker 400 MHz NMR spectrometer, operating at 400 and 100 MHz, respectively. Chemical shifts are reported in ppm relative to TMS or the deuterated solvent as the internal reference. Fourier transform infrared (FTIR) analyses were performed with a PerkinElmer SP One FTIR spectrophotometer. Microanalyses were performed with a Carlo Erba 1106 Elemental Analyzer. Hydroximyl chlorides 3a−k are known compounds and were prepared from the corresponding readily available aldehydes via the reported method.²⁶ Other reagents and solvents were purchased from commercial suppliers and were used as received without further purification. All experiments were carried out in air. Analytical thin-layer chromatography (TLC) was carried out on Merck 0.2 mm silica gel 60 F254 analytical aluminum plates, and the products were visualized by UV detection. Column chromatography was performed on Merck silica gel 60 (250–400 mesh).

Preparation of N,N-bis(isoxazol-5-yl)methyl tertiary arylamines 4aa–di; general procedure

To a stirred solution of primary aromatic amine 1 (1.0 mmol) in DMF (5 mL) was added CaH₂ (20 mg, 0.4 mmol) and propargyl bromide (480 mg, 4.0 mmol). The resulting mixture was stirred at room temperature until complete conversion of the amine into the N,N-di(prop-2-yn-1-yl)arylamine 2 had occurred (as monitored by TLC). The excess of propargyl bromide was then removed under reduced pressure. Next, hydroximyl chloride 3 (2.5 mmol) and Et₃N (3.0 mmol) were added to the reaction mixture, which was warmed to 65 °C and stirred until completion of the reaction (as monitored by TLC). The resulting solution was filtered through a short pad of Celite 545 and the solvent was removed under reduced pressure. The crude product was purified by column chromatography on silica gel (petroleum ether/EtOAc = 10:1) to afford the target compound 4.

N,N-Bis[(3-phenylisoxazol-5-yl)methyl]aniline (4aa)

Yellow solid, m.p. = 112–113 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.84–7.82 (m, 5H), 7.50–7.48 (m, 8H), 7.33 (s, 2H), 6.95 (s, 2H), 4.61 (s, 4H). ¹³C NMR (100 MHz, DMSO-d₆): δ 169.85, 162.17, 144.93, 132.19, 130.67, 129.32, 128.90, 128.17, 127.05, 126.08, 102.34, 48.23. IR (KBr): ν 3050, 2965, 1607, 1466, 1368, 1269, 1136, 1065, 742 cm⁻¹. Anal. calcd for C₂₆H₂₁N₃O₂: C, 76.64; H, 5.19; N, 10.31; found: C, 76.72; H, 5.29; N, 10.35%.

N,N-Bis[(3-(o-tolyl)isoxazol-5-yl)methyl]aniline (4ab)

Yellow solid, m.p. = 53–55 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.44–7.34 (m, 4H), 7.26–7.13 (m, 7H), 7.06 (dd, J = 8.6, 2.4 Hz, 1H), 6.94 (d, J = 8.6 Hz, 1H), 6.23 (s, 2H), 4.44 (s, 4H), 2.33 (s, 6H). ¹³C NMR (100 MHz, CDCl₃): δ 168.29, 163.05, 144.29, 136.87, 131.28, 131.13, 130.61, 129.42, 128.49, 127.72, 126.04, 125.14, 104.26, 48.46, 21.10. IR (KBr): ν 3035, 2972, 2869, 1602, 1488, 1384, 1291, 1125, 751 cm⁻¹. Anal. calcd for C₂₈H₂₅N₃O₂: C, 77.25; H, 5.75; N, 9.65; found: C, 77.32; H, 5.89; N, 9.73%.

N,N-Bis[(3-(m-tolyl)isoxazol-5-yl)methyl]aniline (4ac)

Yellow solid, m.p. = 83–84 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.57–7.51 (m, 4H), 7.30–7.20 (m, 6H), 6.87–6.82 (m, 3H), 6.43 (s, 2H), 4.72 (s, 4H), 2.35 (s, 6H). ¹³C NMR (100 MHz, CDCl₃): δ 169.86, 162.68, 147.13, 138.68, 130.90, 129.60, 128.84, 128.68, 127.47, 124.00, 119.09, 113.59, 100.79, 47.48, 21.37. IR (KBr): ν 3033, 2975, 2872, 1605, 1490, 1386, 1290, 1127, 757, 698 cm⁻¹. Anal. calcd for C₂₈H₂₅N₃O₂: C, 77.25; H, 5.75; N, 9.65; found: C, 77.38; H, 5.90; N, 9.71%.

N,N-Bis{[3-(3-methoxyphenyl)isoxazol-5-yl]methyl}aniline (4ad)

Yellow solid, m.p. = 65–67 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.29–7.04 (m, 8H), 6.83–6.73 (m, 5H), 6.55 (s, 2H), 4.69 (s, 4 H), 3.70 (s, 6H). ¹³C NMR (100 MHz, CDCl₃): δ 169.19, 161.21, 158.34, 147.18, 131.19, 129.53, 128.86, 124.16, 119.25, 117.54, 115.30, 113.84, 104.10, 55.68, 47.50. IR (KBr): ν 3430, 3045, 2927, 2848, 1605, 1508, 1248, 1178, 1030, 897, 752, 694 cm⁻¹. Anal. calcd for C₂₈H₂₅N₃O₄: C, 71.96; H, 5.35; N, 8.99; found: C, 71.85; H, 5.46; N, 8.92%.

N,N-Bis[(3-phenylisoxazol-5-yl)methyl]-3-methylaniline (4ba)

Yellow solid, m.p. = 145–146 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.78–7.75 (m, 5H), 7.44–7.43 (m, 9H), 6.47 (s, 2H), 4.50 (s, 4H), 2.52 (s, 3H). ¹³C NMR (100 MHz, CDCl₃): δ 169.43, 162.42, 146.23, 135.69, 133.91, 130.83, 130.11, 128.90, 127.59, 126.83, 125.88, 122.05, 101.53, 48.52, 19.21. IR (KBr): ν 3031, 2972, 2870, 1604, 1495, 1385, 1288, 1125, 862, 765, 700 cm⁻¹. Anal. calcd for C₂₇H₂₃N₃O₂: C, 76.94; H, 5.50; N, 9.97; found: C, 76.82; H, 5.64; N, 9.91%.

N,N-Bis{[(3-(o-tolyl)isoxazol-5-yl)]methyl}-3-methylaniline (4bb)

Yellow solid, m.p. = 62–63 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.73–7.70 (m, 2H), 7.32–7.20 (m, 8H), 6.78 (s, 2H), 6.33 (s, 2H), 4.66 (s, 4H), 2.44 (s, 6H), 2.34 (s, 3H). ¹³C NMR (100 MHz, CDCl₃): δ 169.04, 163.12, 146.21, 136.80, 133.47, 131.10, 130.93, 129.53, 129.42, 128.86, 126.00, 125.05, 117.12, 113.57, 103.51, 47.65, 20.56, 19.21. IR (KBr): ν 3040, 2978, 2875, 1603, 1489, 1385, 1287, 1122, 857, 768 cm⁻¹. Anal. calcd for C₂₉H₂₇N₃O₂: C, 77.48; H, 6.05; N, 9.35; found: C, 77.58; H, 6.16; N, 9.43%.

N,N-Bis{[(3-(m-tolyl)isoxazol-5-yl)methyl]-3-methylaniline (4bc)

Yellow solid, m.p. = 86–87 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.51–7.45 (m, 5H), 7.25–7.07 (m, 6H), 6.86–6.78 (m, 1H), 6.37 (s, 2H), 4.38 (s, 4H), 2.43 (s, 3H), 2.30 (s, 6H). ¹³C NMR (100 MHz, CDCl₃): δ 169.27, 162.52, 144.55, 138.67, 136.07, 131.43, 130.86, 128.81, 128.70, 127.58, 127.41, 126.23, 123.98, 122.07, 101.60, 48.49, 21.37. IR (KBr): ν 3037, 2974, 2883, 1606, 1491, 1382, 1285, 1126, 865, 772, 765 cm⁻¹. Anal. calcd for C₂₉H₂₇N₃O₂: C, 77.48; H, 6.05; N, 9.35; found: C, 77.60; H, 6.14; N, 9.44%.

N,N-Bis[(3-phenylisoxazol-5-yl)methyl]-2-methylaniline (4ca)

Yellow solid; m.p. = 127–128 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.76–7.53 (m, 4H), 7.52–7.51 (m, 1H), 7.43–7.42 (m, 6H), 7.21 (d, J = 1.8 Hz, 1H), 7.08 (dd, J = 8.6, 2.0 Hz, 1H), 6.93 (d, J = 8.4 Hz, 1H), 6.38 (s, 2H), 4.33 (s, 4H), 2.41 (s, 3H). ¹³C NMR (100 MHz, CDCl₃): δ 169.42, 162.37, 146.34, 136.42, 131.27, 130.94, 130.41, 130.09, 128.90, 126.81, 126.60, 123.87, 101.55, 49.03, 17.96. IR (KBr): ν 3033, 2977, 2886, 1604, 1500, 1384, 1285, 1127, 745 cm⁻¹. Anal. calcd for C₂₇H₂₃N₃O₂: C, 76.94; H, 5.50; N, 9.97; found: C, 76.85; H, 5.62; N, 8.90%.

N,N-Bis{[3-(m-tolyl)isoxazol-5-yl]methyl}-2-methylaniline (4cc)

Yellow solid, m.p. = 57–58 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.73–7.70 (m, 2H), 7.55–7.52 (m, 3H), 7.32 (t, J = 7.6 Hz, 2H), 7.23 (dd, J = 9.9, 4.9 Hz, 3H), 7.08 (dd, J = 8.5, 2.4 Hz, 1H), 6.93 (d, J = 8.5 Hz, 1H), 6.37 (s, 2H), 4.33 (s, 4H), 2.41 (s, 3H), 2.39 (s, 6H). ¹³C NMR (100 MHz, CDCl₃): δ 169.27, 162.47, 146.39, 138.67, 131.38, 131.25, 130.68, 129.23, 128.95, 128.86, 128.82, 127.39, 126.59, 123.95, 101.60, 49.02, 21.37, 19.20. IR (KBr): ν 3033, 2975, 2887, 1604, 1490, 1384, 1282, 1122, 862, 770, 745 cm⁻¹. Anal. calcd for C₂₉H₂₇N₃O₂: C, 77.48; H, 6.05; N, 9.35; found: C, 77.61; H, 6.16; N, 9.47%.

N,N-Bis{[3-(3-methoxyphenyl)isoxazol-5-yl]methyl}-2-methylaniline (4cd)

Yellow solid, m.p. = 65–66 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.32 (d, J = 8.9 Hz, 3H), 7.23–7.21 (m, 4H), 7.11 (d, J = 7.5 Hz, 1H), 7.04 (t, J = 7.1 Hz, 2H), 6.89 (dd, J = 8.9, 3.1 Hz, 2H), 6.56 (s, 2H), 4.39 (s, 4H), 3.78 (s, 6H), 2.43 (s, 3H). ¹³C NMR (100 MHz, CDCl₃): δ 169.17, 160.98, 158.33, 147.74, 134.46, 131.30, 130.94, 128.82, 126.62, 125.27, 124.17, 122.69, 117.44, 115.23, 104.78, 55.66, 49.14, 18.03. IR (KBr): ν 3028, 2951, 1602, 1467, 1238, 1031, 823, 647 cm⁻¹. Anal. calcd for C₂₉H₂₇N₃O₄: C, 72.33; H, 5.65; N, 8.73; found: C, 72.16; H, 5.77; N, 8.85%.

N,N-Bis{[3-(4-chlorophenyl)isoxazol-5-yl]methyl}-2-methylaniline (4ce)

Yellow solid, m.p. = 123–124 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.73–7.71 (m, 2H), 7.66 (d, J = 8.8 Hz, 4 H), 7.43–7.40 (m, 2H), 7.38 (d, J = 8.4 Hz, 4H), 6.34 (s, 2H), 4.36 (s, 4H), 2.45 (s, 3H). ¹³C NMR (100 MHz, CDCl₃): δ 170.18, 161.37, 147.90, 136.05, 131.54, 130.93, 129.14, 128.85, 128.04, 126.68, 125.33, 122.32, 101.25, 49.28, 19.20. IR (KBr): ν 3036, 2956, 2788, 1604, 1495, 1386, 1235, 1028, 905, 834, 760, 705 cm⁻¹. Anal. calcd for C₂₇H₂₁N₃Cl₂O₂: C, 66.13; H, 4.32; N, 8.57; found: C, 66.25; H, 4.41; N, 8.49%.

N,N-Bis{[3-(4-bromophenyl)isoxazol-5-yl]methyl}-2-methylaniline (4cf)

Yellow solid, m.p. = 132–133 °C. ¹H NMR (400 MHz, CDCl₃): δ 7.73–7.70 (m, 2H), 7.60–7.50 (m, 8H), 7.05 (dd, J = 8.0, 19.6 Hz, 2H), 6.34 (s, 2H), 4.35 (s, 4H), 2.45 (s, 3H). ¹³C NMR (100 MHz, CDCl₃): δ 170.21, 161.43, 147.90, 132.20, 131.54, 130.92, 128.56, 127.81, 126.68, 125.34, 124.32, 122.32, 101.21, 49.29, 19.20. IR (KBr): ν 3036, 2956, 2788, 1604, 1495, 1382, 1233, 1073, 905, 832, 757, 695 cm⁻¹. Anal. calcd for C₂₇H₂₁N₃Br₂O₂: C, 55.98; H, 3.65; N, 7.25; found: C, 55.85; H, 3.76; N, 7.16%.

N,N-Bis{[3-(4-nitrophenyl)isoxazol-5-yl]methyl}-2-methylaniline (4cg)

Yellow solid, m.p. = 153–154 °C. ¹H NMR (400 MHz, CDCl₃): δ 8.27 (d, J = 8.8 Hz, 4H), 7.73–7.68 (m, 4H), 7.43 (d, J = 8.8 Hz, 4H), 6.45 (s, 2H), 4.37 (s, 4H), 2.51 (s, 3H). ¹³C NMR (100 MHz, CDCl₃): δ 170.23, 162.33, 148.34, 147.93, 134.45, 131.58, 130.96, 128.85, 128.04, 126.69, 124.33, 122.35, 101.28, 49.31, 19.29. IR (KBr): ν 3072, 2935, 2855, 1604, 1510, 1495, 1445, 1382, 1345, 1135, 1108, 925, 850 cm⁻¹. Anal. calcd for C₂₇H₂₁N₅O₆: C, 63.40; H, 4.14; N, 13.69; found: C, 63.25; H, 4.26; N, 13.57%.

4-Chloro-N,N-bis[(3-benzylisoxazol-5-yl)methyl]aniline (4dh)

Yellow solid, m.p. = 97–99 °C. δ 7.35–7.33 (m, 6H), 7.19–7.16 (m, 4H), 7.08 (d, J = 8.6 Hz, 2H), 6.75 (d, J = 8.6 Hz, 2H), 6.30 (s, 2H), 4.63 (s, 4H), 4.29 (s, 4H). ¹³C NMR (100 MHz, CDCl₃): δ 170.27, 161.52, 147.96, 134.66, 131.15, 129.12, 128.73, 127.88, 123.00, 115.17, 101.22, 47.22, 32.42. IR (KBr): ν 3034, 2970, 2785, 1603, 1490, 1235, 1026, 906, 835, 760, 699 cm⁻¹. Anal. calcd for C₂₈H₂₄ClN₃O₂: C, 71.56; H, 5.15; N, 8.94; found: C, 71.42; H, 5.24; N, 8.86%.

4-Chloro-N,N-bis[(3-propylisoxazol-5-yl)methyl]aniline (4di)

Yellow liquid. δ 7.56 (d, J = 8.8 Hz, 2H), 7.01 (d, J = 8.8 Hz, 2H), 6.26 (s, 2H), 4.38 (s, 4H), 2.37 (t, J = 7.2 Hz, 4H), 1.68–1.67 (m, 4H), 1.11 (t, J = 7.2 Hz, 6H). ¹³C NMR (100 MHz, CDCl₃): δ 169.67, 160.92, 146.80, 132.46, 128.94, 115.22, 100.76, 47.02, 30.07, 19.78, 13.89. IR (film): ν 3034, 2962, 2932, 1608, 1455, 1016, 760, 698 cm⁻¹. Anal. calcd for C₁₈H₂₄ClN₃O₂: C, 61.79; H, 6.91; N, 12.01; found: C, 61.93; H, 6.80; N, 12.11%.

Supplemental Material

supplemental_material – Supplemental material for One-pot synthesis of novel N,N-bis(isoxazol-5-yl)methyl tertiary arylamines via sequential diprop-3-ynylation and 1,3-dipolar cycloaddition from primary amines

Supplemental material, supplemental_material for One-pot synthesis of novel N,N-bis(isoxazol-5-yl)methyl tertiary arylamines via sequential diprop-3-ynylation and 1,3-dipolar cycloaddition from primary amines by Xiao-Lan Zhang, Mei-Hong Wei, Shou-Ri Sheng and Xiao-Ling Liu in Journal of Chemical Research

Footnotes

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: We are grateful to the Research Program of Jiangxi Province Department of Education (Nos GJJ170934, GJJ160289, and GJJ11380), the Opening Foundation of National Research Center for Carbohydrate Synthesis (No. GJDTZX-KF-201414), and the Opening Foundation of the Key Laboratory of Functional Small Organic Molecules of Ministry of Education (No. KLFS-KF-201411) for the financial support.

ORCID iD

Xiao-Ling Liu

Supplemental material

Supplemental material for this article is available online.

References

Lawrence

SA.

Amines: synthesis, properties and applications. Cambridge: Cambridge University Press, 2004.

Gagewy

Chem Rev 2008; 108: 5227.

Karaki

Ohgane

Fukuda

et al. Bioorg Med Chem 2014; 22: 3587.

Corpet

Gosmini

Synthesis 2014; 46: 2258.

Grünanger

Vita-Finzi

Isoxazoles: The Chemistry of Heterocyclic Compounds. New York: John Wiley, 1991.

Pinho

Teresa

MVD

. Recent advances on the synthesis and reactivity of isoxazoles. Curr Org Chem 2005; 9: 925–958.

Padwa

(ed.). 1,3-Dipolar Cycloaddition Chemistry. New York: John Wiley, 1984.

Heaney

Eur J Org Chem 2012; 3043.

Szostak

Adv Synth Catal 2015; 357: 2583.

10.

Singh

Chowdhury

Koley

Tetrahedron 2016; 72: 1603.

11.

Morita

Yugandar

Fuse

et al. Tetrahedron Lett 2018; 59: 1159.

12.

Elnagdi

Elmoghayar

MRH

Hafez

EAA

et al. J Org Chem 1975; 40: 2604.

13.

Bourbeau

Rider

JT.

Org Lett 2006; 8: 3679.

14.

Wenli

Peterson

Keelson

et al. J Comb Chem 2009; 11: 697.

15.

Johnson

Powers

et al. Synthesis 2013; 45: 171.

16.

Shimkin

Gildner

Watson

DA.

Org Lett 2016; 18: 988.

17.

Moore

Spinks

Harritya

JPA

. Tetrahedron Lett 2004; 45: 3189.

18.

Girardin

Alsabeh

Lauzon

et al. Org Lett 2009; 11: 1159.

19.

Samai

Chanda

Ila

et al. Eur J Org Chem 2013; 4026.

20.

Averina

Vasilenko

Samoilichenko

et al. Synthesis 2014; 46: 1107.

21.

Andreev

Medvedeva

Larina

et al. Mendeleev Commun 2017; 27: 175.

22.

Zhu

Bienaymé

(eds). Multicomponent Reactions. Weinheim: Wiley, 2005.

23.

Döling

Wang

Chem Rev 2012; 112: 3083.

24.

Rotstein

Zaretsky

Rai

et al. Chem Rev 2014; 114: 8323.

25.

W-Q

P-H

Yang

et al. Chem Commun 2017; 53: 8482.

26.

Dubrovskiy

Larock

RC.

Org Lett 2010; 12: 1180.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.20 MB